A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

Clinical trial NCT01678924 · TERMINATED

Trial details

NCT number: NCT01678924
Sponsor: Allergan
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuralgia, Postherpetic

Start date: 2013-01-01
Primary completion: 2015-05-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.